Skip to main content

Evoke Pharma, Inc. (EVOK)

NASDAQ: EVOK · IEX Real-Time Price · USD
1.21
-0.05 (-3.97%)
Dec 8, 2023, 3:51 PM EST - Market closed

Evoke Pharma Revenue

Evoke Pharma had revenue of $4.30M in the twelve months ending September 30, 2023, with 107.49% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $1.56M with 87.82% year-over-year growth. In the year 2022, Evoke Pharma had annual revenue of $2.51M with 55.04% growth.

Revenue (ttm)
$4.30M
Revenue Growth
+107.49%
P/S Ratio
0.94
Revenue / Employee
$1,075,252
Employees
4
Market Cap
4.05M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20222.51M890.57K
55.04%
Dec 31, 20211.62M1.60M
6,929.00%
Dec 31, 202023.02K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Dec 31, 20110--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

EVOK News

More News